ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond.

Alessandra Zanetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.